Matches in SemOpenAlex for { <https://semopenalex.org/work/W2908241791> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W2908241791 startingPage "78" @default.
- W2908241791 abstract "According to IDF, more than 425 million people in the age of 20 to 79 all around the world are suffering from type 2 diabetes. In 2045, the number of people will reach 629 million. Such a rapid increase in the prevalence of type 2 diabetes is associated with increasing of patients with obesity. A whole range of mechanisms involving many organs and hormonal systems supports glucose homeostasis, and dysfunction of this systems leads to the development and progression of insulin resistance and the development of complications. Early start of therapy that aimed at the maximum number of pathophysiological targets can slow the progression of disease and prevent. The purpose of our study is to evaluate the influence of combined therapy of sitagliptin and metformin on fat metabolism in patients with type 2 diabetes mellitus. The study included 82 patients (age, 55.3±9.1 years) with obesity and lipid metabolism disorders. None of the patients had reached their target glycated hemoglobin levels after metformin and diet therapy. Patients in group 1 (n=42) received 1.5–2-g metformin daily before the study and were switched to a formulation of 100-mg sitagliptin and 2-g metformin once a day. Patients in group 2 (n=40) were on a diet therapy before inclusion and were started on 2-g metformin/day. The following were evaluated at baseline and after 6 months of therapy: fasting glucose levels, postprandial glucose levels, glycated hemoglobin, weight, body mass index, waist circumference and lipid profile; insulin, proinsulin, leptin and adiponectin levels; insulin resistance using the homeostatic model assessment (HOMA) of β-cell function (HOMA-β) and insulin resistance (HOMA-IR). In addition, magnetic resonance imaging was performed to assess the amount of visceral fat for the total cohort. As the result of intensification of therapy by adding sitagliptin to metformin, in patients with type 2 diabetes, compared to monotherapy with metformin, we got more pronounced important non – glycemic effects in the form of a decrease in the visceral fat depot, an improvement in functional activity of pancreatic β-cells, which is the leading pathogenesis mechanism for improving glycemic control." @default.
- W2908241791 created "2019-01-11" @default.
- W2908241791 creator A5041986885 @default.
- W2908241791 creator A5077547326 @default.
- W2908241791 date "2019-01-03" @default.
- W2908241791 modified "2023-09-26" @default.
- W2908241791 title "Influence of IDPP-4 on Fat Metabolism in Patients with Type 2 Diabetes" @default.
- W2908241791 doi "https://doi.org/10.11648/j.ijcems.20180406.11" @default.
- W2908241791 hasPublicationYear "2019" @default.
- W2908241791 type Work @default.
- W2908241791 sameAs 2908241791 @default.
- W2908241791 citedByCount "0" @default.
- W2908241791 crossrefType "journal-article" @default.
- W2908241791 hasAuthorship W2908241791A5041986885 @default.
- W2908241791 hasAuthorship W2908241791A5077547326 @default.
- W2908241791 hasConcept C126322002 @default.
- W2908241791 hasConcept C134018914 @default.
- W2908241791 hasConcept C2776782570 @default.
- W2908241791 hasConcept C2777180221 @default.
- W2908241791 hasConcept C2777391703 @default.
- W2908241791 hasConcept C2777538456 @default.
- W2908241791 hasConcept C2779284873 @default.
- W2908241791 hasConcept C2779306644 @default.
- W2908241791 hasConcept C2780323712 @default.
- W2908241791 hasConcept C2910068830 @default.
- W2908241791 hasConcept C555293320 @default.
- W2908241791 hasConcept C71924100 @default.
- W2908241791 hasConceptScore W2908241791C126322002 @default.
- W2908241791 hasConceptScore W2908241791C134018914 @default.
- W2908241791 hasConceptScore W2908241791C2776782570 @default.
- W2908241791 hasConceptScore W2908241791C2777180221 @default.
- W2908241791 hasConceptScore W2908241791C2777391703 @default.
- W2908241791 hasConceptScore W2908241791C2777538456 @default.
- W2908241791 hasConceptScore W2908241791C2779284873 @default.
- W2908241791 hasConceptScore W2908241791C2779306644 @default.
- W2908241791 hasConceptScore W2908241791C2780323712 @default.
- W2908241791 hasConceptScore W2908241791C2910068830 @default.
- W2908241791 hasConceptScore W2908241791C555293320 @default.
- W2908241791 hasConceptScore W2908241791C71924100 @default.
- W2908241791 hasIssue "6" @default.
- W2908241791 hasLocation W29082417911 @default.
- W2908241791 hasOpenAccess W2908241791 @default.
- W2908241791 hasPrimaryLocation W29082417911 @default.
- W2908241791 hasRelatedWork W1964983763 @default.
- W2908241791 hasRelatedWork W1977575596 @default.
- W2908241791 hasRelatedWork W1978993973 @default.
- W2908241791 hasRelatedWork W2000133211 @default.
- W2908241791 hasRelatedWork W2013991546 @default.
- W2908241791 hasRelatedWork W2015254547 @default.
- W2908241791 hasRelatedWork W2021842632 @default.
- W2908241791 hasRelatedWork W2032151034 @default.
- W2908241791 hasRelatedWork W2046842568 @default.
- W2908241791 hasRelatedWork W2062696374 @default.
- W2908241791 hasRelatedWork W2084761742 @default.
- W2908241791 hasRelatedWork W2377538382 @default.
- W2908241791 hasRelatedWork W2411807913 @default.
- W2908241791 hasRelatedWork W2616011654 @default.
- W2908241791 hasRelatedWork W2769453136 @default.
- W2908241791 hasRelatedWork W2981766641 @default.
- W2908241791 hasRelatedWork W3006052521 @default.
- W2908241791 hasRelatedWork W3031113614 @default.
- W2908241791 hasRelatedWork W3116280894 @default.
- W2908241791 hasRelatedWork W3186973534 @default.
- W2908241791 hasVolume "4" @default.
- W2908241791 isParatext "false" @default.
- W2908241791 isRetracted "false" @default.
- W2908241791 magId "2908241791" @default.
- W2908241791 workType "article" @default.